Table 1. Effects of beauveriolides and other compounds on CE synthesis and ACAT activity.
| ACAT
|
|||||
|---|---|---|---|---|---|
| Compound | CE synthesis in macrophage | Postlysosomal cholesterol metabolism | Mouse macrophage | Mouse liver | Caco-2 |
| Beauveriolide I | 0.78 | 0.37 | 6.0 | 1.5 | 2.5 |
| Beauveriolide III | 0.41 | 0.21 | 5.5 | 1.5 | 1.0 |
| Beauvericin | 0.13 | 0.01 | 1.0 | 8.0 | NT |
| Cytochalasin D | 2.4 | >20 | NT | >100 | NT |
| CL-283,546 | 0.035 | 0.04 | 0.001 | 0.005 | 0.055 |
IC50 values stated are micromolar. NT, not tested.